0000950170-24-028195.txt : 20240307 0000950170-24-028195.hdr.sgml : 20240307 20240307175328 ACCESSION NUMBER: 0000950170-24-028195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Financial LP CENTRAL INDEX KEY: 0001290162 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 24731591 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 ownership.xml 4 X0508 4 2024-03-07 0001635088 Roivant Sciences Ltd. ROIV 0001290162 QVT Financial LP 888 SEVENTH AVENUE, 43RD FLOOR NEW YORK NY 10106 false false true true Director by Deputization false Common Shares 2024-03-07 4 J false 45361 0.00 D 55443 I Held by Fourth Avenue Capital Partners LP Common Shares 2024-03-07 4 J false 11077765 0.00 D 14646796 I Held by QVT Deferred Compensation Holdings Ltd. Common Shares 2024-03-07 4 J false 11325233 0.00 D 23105358 I Held by QVT Financial Investment Cayman Ltd. Common Shares 2024-03-07 4 J false 15518673 0.00 D 19311790 I Held by QVT Roiv Hldgs Offshore Ltd Common Shares 2024-03-07 4 J false 5594064 0.00 D 6837266 I Held by QVT Roiv Hldgs Onshore Ltd. Common Shares 2024-03-07 4 J false 2260661 0.00 D 2763126 I Held by QVT P&E Roiv Hldgs Ltd. On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 66,719,779 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. QVT is the investment manager of QVT Roiv, shares voting and investment control over the Shares held directly by QVT Roiv and therefore may be deemed to beneficially own such Shares. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. /s/ Meg Eisner 2024-03-07